Evidence map›Paper›PMID 37225900›Full record

ArticleAnalytical and bioanalytical chemistry2023

Augmented region of interest for untargeted metabolomics mass spectrometry (AriumMS) of multi-platform-based CE-MS and LC-MS data.

Lukas Naumann, Adrian Haun, Alisa Höchsmann, Michael Mohr, Martin Novák, Dirk Flottmann, Christian Neusüß

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Automated Near Real-Time QC for LC-HRMS.Rapid communications in mass spectrometry : RCM · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lukas Naumann *Department of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany.ORCID http://orcid.org/0000-0003-2103-9548
Adrian Haun *Department of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany.ORCID http://orcid.org/0000-0002-4988-8683
Alisa HöchsmannDepartment of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany.
Michael MohrDepartment of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany.
Martin NovákDepartment of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany.
Dirk FlottmannDepartment of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany.
Christian NeusüßDepartment of Chemistry, Aalen University, Beethovenstraße 1, 73430, Aalen, Germany. Christian.Neusuess@hs-aalen.de.ORCID http://orcid.org/0000-0003-2404-4924
Hochschule Aalen · DE

Funding

Bundesministerium für Bildung und Forschung 13FH635IB6
6 · The paper itself

Abstract

In mass spectrometry (MS)-based metabolomics, there is a great need to combine different analytical separation techniques to cover metabolites of different polarities and apply appropriate multi-platform data processing. Here, we introduce AriumMS (augmented region of interest for untargeted metabolomics mass spectrometry) as a reliable toolbox for multi-platform metabolomics. AriumMS offers augmented data analysis of several separation techniques utilizing a region-of-interest algorithm. To demonstrate the capabilities of AriumMS, five datasets were combined. This includes three newly developed capillary electrophoresis (CE)-Orbitrap MS methods using the recently introduced nanoCEasy CE-MS interface and two hydrophilic interaction liquid chromatography (HILIC)-Orbitrap MS methods. AriumMS provides a novel mid-level data fusion approach for multi-platform data analysis to simplify and speed up multi-platform data processing and evaluation. The key feature of AriumMS lies in the optimized data processing strategy, including parallel processing of datasets and flexible parameterization for processing of individual separation methods with different peak characteristics. As a case study, Saccharomyces cerevisiae (yeast) was treated with a growth inhibitor, and AriumMS successfully differentiated the metabolome based on the augmented multi-platform CE-MS and HILIC-MS investigation. As a result, AriumMS is proposed as a powerful tool to improve the accuracy and selectivity of metabolome analysis through the integration of several HILIC-MS/CE-MS techniques.

Indexed as

MetabolomicsTandem Mass SpectrometryChromatography, LiquidElectrophoresis, CapillaryMetabolomeAugmented data evaluationCapillary electrophoresisHydrophilic interaction liquid chromatographyMid-level data fusionMulti-platform metabolomicsnanoCEasy

Identifiers

PMID37225900
PMCPMC10287804
OpenAlexW4377965311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.